FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.22-SNAPSHOT | FHIR Version n/a User: [n/a]

442749005: Fenofibric acid (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Peroxisome proliferator-activated receptor agonist\Peroxisome proliferator-activated alpha receptor agonist\Fenofibrate (substance)\Fenofibric acid

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Peroxisome proliferator-activated receptor agonist\Peroxisome proliferator-activated alpha receptor agonist\Fenofibrate (substance)\Fenofibric acid
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Antilipemic agent (substance)\Peroxisome proliferator-activated alpha receptor agonist\Fenofibrate (substance)\Fenofibric acid

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Halogen and/or halogen compound\Chlorine and/or chlorine compound\Chlorine compound\Organic chloride compound\Chlorinated hydrocarbon\Chlorobenzene\Fenofibrate (substance)\Fenofibric acid
\Halogen and/or halogen compound\Halogenated hydrocarbon\Chlorinated hydrocarbon\Chlorobenzene\Fenofibrate (substance)\Fenofibric acid

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2009. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2820801013 Fenofibric acid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2820802018 Fenofibric acid (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Fenofibric acid	Is a	Peroxisome proliferator-activated alpha receptor agonist	false	Inferred relationship	Some
Fenofibric acid	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Peroxisome proliferator-activated alpha receptor agonist (disposition)	true	Inferred relationship	Some
Fenofibric acid	Is a	Fibric acid and/or fibric acid derivative (substance)	false	Inferred relationship	Some
Fenofibric acid	Is a	Fenofibrate (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fenofibric acid 135mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fenofibric acid	Inferred relationship	Some
Product containing fenofibric acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fenofibric acid	Inferred relationship	Some	1
Fenofibric acid 45mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fenofibric acid	Inferred relationship	Some
Fenofibric acid 35 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fenofibric acid	Inferred relationship	Some
Fenofibric acid 105 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fenofibric acid	Inferred relationship	Some
Fenofibric acid 35 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fenofibric acid	Inferred relationship	Some	1
Fenofibric acid 35 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fenofibric acid	Inferred relationship	Some	1
Fenofibric acid 105 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fenofibric acid	Inferred relationship	Some	1
Fenofibric acid 105 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fenofibric acid	Inferred relationship	Some	1
Product containing precisely fenofibric acid 45 milligram/1 each gastro-resistant oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fenofibric acid	Inferred relationship	Some
Fenofibric acid 135 mg gastro-resistant oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fenofibric acid	Inferred relationship	Some
Fenofibric acid 35 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fenofibric acid	Inferred relationship	Some	1
Fenofibric acid 105 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fenofibric acid	Inferred relationship	Some	1
Fenofibric acid-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fenofibric acid	Inferred relationship	Some	1
Product containing only fenofibric acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fenofibric acid	Inferred relationship	Some	1
Product containing only fenofibric acid in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fenofibric acid	Inferred relationship	Some	1
Product containing precisely fenofibric acid 45 milligram/1 each gastro-resistant oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fenofibric acid	Inferred relationship	Some	1
Product containing precisely fenofibric acid 45 milligram/1 each gastro-resistant oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fenofibric acid	Inferred relationship	Some	1
Fenofibric acid 135 mg gastro-resistant oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Fenofibric acid	Inferred relationship	Some	1
Fenofibric acid 135 mg gastro-resistant oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Fenofibric acid	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2820801013	Fenofibric acid	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2820802018	Fenofibric acid (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core